{"Title": "Treatment regimens for rifampicin-resistant tuberculosis: Highlighting a research gap", "Year": 2016, "Source": "Int. J. Tuberc. Lung Dis.", "Volume": "20", "Issue": 10, "Art.No": null, "PageStart": 1418, "PageEnd": 1419, "CitedBy": 0, "DOI": "10.5588/ijtld.16.0485", "Link": "https://www.scopus.com/inward/record.uri?partnerID=HzOxMe3b&scp=84987638448&origin=inward", "Abstract": null, "AuthorKeywords": null, "IndexKeywords": ["Antitubercular Agents", "Humans", "Mycobacterium tuberculosis", "Rifampin", "Tuberculosis, Multidrug-Resistant"], "DocumentType": "Journal", "PublicationStage": null, "OpenAccess": 0, "EID": "2-s2.0-84987638448", "SubjectAreas": [["Pulmonary and Respiratory Medicine", "MEDI", "2740"], ["Infectious Diseases", "MEDI", "2725"]], "AuthorData": {"7102771386": {"Name": "Nunn A.", "AuthorID": "7102771386", "AffiliationID": "60003108, 60022148", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology"}, "57190394071": {"Name": "Tweed C.", "AuthorID": "57190394071", "AffiliationID": "60003108, 60022148", "AffiliationName": "MRC Clinical Trials Unit at UCL, Institute of Clinical Trials and Methodology"}}}